Journal List > J Korean Ophthalmol Soc > v.53(5) > 1009354

Kim and Yang: Comparison of Surgical Outcomes between Trabeculectomy and Aqueous Shunt Surgery in Patients with Iridocorneal Endothelial Syndrome

Abstract

Purpose

To compare surgical outcomes and corneal endothelial cell densities in patients with glaucoma secondary to iridocorneal endothelial (ICE) syndrome who underwent trabeculectomy with mitomycin-C (MMC) versus those who underwent Ahmed Glaucoma Valve (AGV) implantation.

Methods

Twenty-one patients with ICE syndrome who underwent either trabeculectomy with MMC or AGV implantation were included in this study. All patients had more than 12 months of follow-up after glaucoma surgery. Intraocular pressure (IOP), visual acuity (VA) and corneal endothelial cell density were compared according to the method of surgery.

Results

Ten eyes had undergone a trabeculectomy with MMC, and 11 eyes had an AGV implantation. In eyes that underwent a trabeculectomy with a MMC, there were no statistically significant differences between preoperative and postoperative month 12 in IOP, VA or corneal endothelial cell density. In eyes that underwent AGV implantation, postoperative IOP, VA and corneal endothelial cell density were statistically significantly lower than the preoperative values.

Conclusions

When determining the method of glaucoma surgery in patients with ICE syndrome, the additional procedures needed to maintain the surgical success of trabeculectomy with MMC and the corneal decompensation which is caused by a decrease in corneal endothelial cell density after AGV implantation should be considered.

Figures and Tables

Figure 1
The changes in mean intraocular pressure (IOP) during the follow-up period. *Significantly higher intraocular pressure between the 2 groups (p < 0.05, independent t-test).
jkos-53-668-g001
Figure 2
The changes in visual acuity in the groups during the follow-up period. There is no significant difference between the two groups at all the time points.
jkos-53-668-g002
Figure 3
The changes in corneal endothelial cell counts in the groups during the follow-up period. There is no significant difference between two groups at all the time points.
jkos-53-668-g003
Table 1
Comparison of baseline characteristics and final surgical outcome between trabeculectomy group and valve implantation group
jkos-53-668-i001

Values are presented as mean ± SD unless otherwise indicated.

*Independent t-test; Fisher's exact test.

Table 2
Comparison of visual acuity between trabeculectomy and Ahmed valve implantation group at 12 month
jkos-53-668-i002

Values are presented as mean ± SD.

*Wilcoxon's rank sum test; Wilcoxon's signed rank test; Paired t-test.

Table 3
Comparison of intraocular pressure between trabeculectomy and Ahmed valve implantation group at 12 month
jkos-53-668-i003

Values are presented as mean ± SD.

*Independent t-test; Paired t-test.

Table 4
Comparison of corneal endothelial cell counts between trabeculectomy and Ahmed valve implantation group at 12 month
jkos-53-668-i004

Values are presented as mean ± SD.

CEC = corneal endothelial cell count.

*Independent t-test; Paired t-test.

References

1. Laganowski HC, Kerr Muir MG, Hitchings RA. Glaucoma and the iridocorneal endothelial syndrome. Arch Ophthalmol. 1992. 110:346–350.
2. Kidd M, Hetherington J, Magee S. Surgical results in iridocorneal endothelial syndrome. Arch Ophthalmol. 1988. 106:199–201.
3. Shields MB, Campbell DG, Simmons RJ. The essential iris atrophies. Am J Ophthalmol. 1978. 85:749–759.
4. Patel A, Kenyon KR, Hirst LW, et al. Clinicopathologic features of Chandler's syndrome. Surv Ophthalmol. 1983. 27:327–344.
5. Hetherington J Jr. The spectrum of Chandler's syndrome. Ophthalmology. 1978. 85:240–244.
6. Scheie HG, Yanoff M. Iris nevus (Cogan-Reese) syndrome. A cause of unilateral glaucoma. Arch Ophthalmol. 1975. 93:963–970.
7. Rodrigues MM, Streeten BW, Spaeth GL. Chandler's syndrome as a variant of essential iris atrophy. A clinicopathologic study. Arch Ophthalmol. 1978. 96:643–652.
8. Boberg-Ans J. Essential progressive iris atrophy. Br J Ophthalmol. 1969. 53:649–651.
9. Wright MM, Grajewski AL, Cristol SM, Parrish RK. 5-Fluorouracil after trabeculectomy and the iridocorneal endothelial syndrome. Ophthalmology. 1991. 98:314–316.
10. Lanzl IM, Wilson RP, Dudley D, et al. Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome. Ophthalmology. 2000. 107:295–297.
11. Kim DK, Aslanides IM, Schmidt CM Jr, et al. Long-term outcome of aqueous shunt surgery in ten patients with iridocorneal endothelial syndrome. Ophthalmology. 1999. 106:1030–1034.
12. Doe EA, Budenz DL, Gedde SJ, Imami NR. Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome. Ophthalmology. 2001. 108:1789–1795.
13. Kim CS, Yim JH, Lee EK, Lee NH. Changes in corneal endothelial cell density and morphology after Ahmed glaucoma valve implantation during the first year of follow up. Clin Experiment Ophthalmol. 2008. 36:142–147.
14. Fiore PM, Richter CU, Arzeno G, et al. The effect of anterior chamber depth on endothelial cell count after filtration surgery. Arch Ophthalmol. 1989. 107:1609–1611.
TOOLS
Similar articles